Document is current
Any future updates will be listed below
-
Authors
Thomas, Christopher A. https://orcid.org/0000-0003-2434-5049
Brinkerhoff, Henry
Craig, Jonathan M. https://orcid.org/0000-0003-4791-5112
Hoshika, Shuichi https://orcid.org/0000-0001-9128-1183
Mihaylova, Desislava
Pfeffer, Akira M.
Franzi, Michaela C.
Abell, Sarah J.
Carrasco, Jessica D.
Gundlach, Jens H. https://orcid.org/0000-0002-0773-8038
Benner, Steven A.
Laszlo, Andrew H. https://orcid.org/0000-0002-7853-0533
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (U24HG011735, R01HG005115)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R01GM128186, R01GM141391)
National Science Foundation (MCB-1939086)
- License Information
-
More Information
Article History
Received: 11 February 2025
Accepted: 8 July 2025
First Online: 6 August 2025
Competing interests
: The authors declare the following competing financial interest(s): S.A.B. owns Firebird Biomolecular Sciences, which makes various ALIEN reagents available for sale. S.H. is affiliated with Firebird Biomolecular Sciences. The remaining authors declare no competing interests.
